Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development IMKTA Q1 2026 Earnings EPS Boost Signals Operational Resilience Amid Sector Headwinds GLOO Q4 2025 Earnings Loss Per Share of 078 Amidst Operational Challenges Incyte Corp INCY Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Dip Keurig Dr Pepper Q1 2026 Earnings Strong EPS Beat Drives Stock Uptick KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Navigates Development